Latest Haematologist News & Updates

FDA Approves First Oral Pill for Thalassemia Treatment

By

New Delhi, Jan 2 (IANS) The US Food and Drug Administration’s (FDA) approval of the first-ever oral pill for anaemia in adults with thalassemia marks a historic milestone and can be a game changer in the management of the genetic blood disorder, said health experts on Friday.The FDA recently approved mitapivat (to be marketed under the brand name Aqvesme) for the treatment of anemia in adults with alpha- or beta-thalassemia.Mitapivat is the first medication indicated for both transfusion-depen…